Pharma R&D Today
Ideas and Insight supporting all stages of Drug Discovery & Development
New Coronavirus Advisory Team Announced
Posted on November 16th, 2020 by Xuanyan Xu in COVID-19
Wasting no time to start enacting his forthcoming administration’s plan for tackling COVID-19, new president-elect of the United States, Joe Biden, has unveiled his coronavirus advisory team. “Dealing with the coronavirus pandemic is one of the most important battles our administration will face, and I will be informed by science and by experts,” he stated.
The Biden transition team announced a slate of medical and public health experts, with three distinguished co-chairs leading the board: Dr. Vivek Murthy (a former Surgeon General), Dr. David Kessler (a professor of pediatrics and former FDA commissioner) and Dr. Marcella Nunez-Smith (Yale School of Medicine physician and researcher).
The other members of the task force include:
*Dr. Luciana Borio, infectious disease expert and public health administrator who has held leadership positions at the FDA and National Security Council
*Dr. Rick Bright, immunologist and vaccine expert who previously served as the director of the Biomedical Advanced Research and Development Authority (Dr. Bright is also known as a whistleblower regarding the current administration’s touting of hydroxychloroquine)
*Dr. Ezekiel Emanuel, oncologist and chair of the Department of Medical Ethics and Health Policy at University of Pennsylvania, who served as a special advisor for health policy under President Obama
*Dr. Atul Gawande, surgeon and public health researcher who was a senior advisor in the Department of Health and Human Services during the Clinton administration
*Dr. Eric Goosby, infectious disease expert who was previously the U.S. Global AIDS Coordinator and currently serves as UN Special Envoy on Tuberculosis.
*Dr. Celine Gounder, a medical journalist and infectious disease specialist who has served as an assistant commissioner and director of the Bureau of Tuberculosis Control at NYC’s Department of Health.
*Dr. Julie Morita, Executive Vice President of the Robert Wood Johnson Foundation and former commissioner of the Chicago Department of Public Health
*Dr. Michael Osterholm, epidemiologist who formerly advised the Health and Human Services secretary under President George W. Bush and currently serves as Director of the Center for Infectious Disease Research and Policy at the University of Minnesota
*Loyce Pace, a Master of Public Health who serves as Executive Director and President of the Global Health Council and has worked on the ground to deliver health programs in several countries
*Dr. Robert Rodriguez, a professor of emergency medicine at the University of California, San Francisco, School of Medicine
The diverse team’s expertise in infectious disease, immunology, epidemiology, vaccine development and public health should ensure that they are able to address the array of challenges presented by the pandemic, from therapeutic research to the implementation of a vaccine.
Many members of the task force have served in previous presidential administrations, and most have already gained experience researching, managing or treating the coronavirus in their current positions. Dr. Robert Rodriguez even went to his hometown of Brownsville, Texas this summer to help with a surge that was occurring in that area along the U.S.-Mexico border.
President-elect Biden has already had his first meeting with the team, and next they will begin consulting with U.S. state and local officials to work on plans to stop the spread and to strategize on how to safely reopen schools and businesses currently shut down because of the pandemic.
Our Life Sciences teams at Elsevier are eager to follow their progress as we continue to share up-to-the-minute information related to COVID-19 through our Coronavirus Research Hub.
R&D Solutions for Pharma & Life SciencesWe're happy to discuss your needs and show you how Elsevier's Solution can help.
Sr. Marketing Manager, Life Sciences Audience at Elsevier
- Lessons learned from the Covid vaccine development process
- Technology and empathy help make remote working a success for Elsevier
- An Update on Global Availability of COVID-19 Vaccines from Editor of The Lancet
- HIV Vaccine Awareness Day
- COVID-19 Treatment Trial Reaches Out to Communities of Color